Cardiac contractility modulation for heart failure, such as pacemaker therapy or implantable cardioverter defibrillators (ICD), Cardiac contractility modulation does not affect the cardiac rhythm directly. Rather, the aim is to enhance the heart’s natural contraction (the native cardiac contractility) sustainably over long periods of time. Furthermore, unlike most interventions that increase cardiac contractility, the Cardiac contractility modulation is not associated with an unfavorable increase in oxygen demand by the heart (measured in terms of Myocardial Oxygen Consumption or MVO). This may be explained by the beneficial effect the therapy has in improving cardiac efficiency. A meta-analysis in 2014 and an overview of device-based
Isovolumetric contraction maintain the correct unidirectional flow of blood through the heart and circulatory system. The word contains the prefix iso-, derived from the Ancient Greek ἴσος (ísos), meaning equal. Therefore, an isovolumetric contraction is one in which the volume of fluid remains constant. Isovolumetric contraction In cardiac physiology, isovolumetric contraction is an event occurring in early systole during which the ventricles contract with no corresponding volume change (isovolumetrically). This short-lasting portion of the cardiac cycle takes place while all heart valves are closed. In a healthy young adult, blood enters the atria and flows to the ventricles via the opened atrioventricular